Sun Pharma inks pact with LIB Therapeutics to sell LDL-C drug

Lerodalcibep is approved in the EU under the brand name Lyrokaul. In the U.S, it is FDA-approved under the brand name Lerochol
More news in Industry
CBI files charge sheet against RCom, others in ₹3,750 crore LIC fraud case
UPI volume jumps 27% to touch 145 bn in first half
FPIs turn net sellers, pull out ₹35,860 crore in September